Richard J. Meelia

This profile gathers the share dealings of Richard J. Meelia across 5 companies, led by Covidien Ltd., Haemonetics Corp and Johnson Controls International plc. The record holds 110 filings, for trades running from 7 March 2006 to 4 June 2021.

On the open market, the record shows 3 purchases worth €890k and 21 sales worth €34.2M. Taken together, the sales exceed the purchases by €33.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 56 share grants and 12 option exercises. In 2021 alone, the filings show no purchases and 1 sale.

A typical purchase (the median) is worth €300k.

The latest filing, published on 8 June 2021, reports a share grant in Conformis Inc. The last purchase on record was published on 26 July 2017, which is 3,392 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.